Planning for Scale from the Start: Where Early Development Decisions Create Commercial Risk
November 9, 2026 | 11:00 AM ET
This webinar will explore how emerging biopharma companies can maintain streamlined clinical development and manufacturing strategies while establishing a strong foundation for commercialization earlier in development.
Through accelerated timelines and connected manufacturing planning, companies can prepare for future demand, reduce scale-up and technology transfer risk, strengthen cross-functional launch readiness, and build a resilient supply strategy as their programs progress.
Attendees will learn how to:
- Plan for commercial demand earlier by considering future scale, capacity, and supply requirements during development
- Reduce development-to-commercial transition risk through an accelerated, connected approach that limits scale-up and technology transfer complexity
- Strengthen launch readiness and supply resilience by aligning development, manufacturing, quality, and supply chain planning from the outset
Nov 5 (Reuters) – Microsoft (MSFT.O), opens new tab will not exercise an option to more than double...
Nov 5 (Reuters) – Apple (AAPL.O), opens new tab is raising about $7.5 billion from a seven-part...
TOKYO/TAIPEI Oct 30 (Reuters) – Asian chip supply chain companies said on Friday that AI-related...
Oct 30 (Reuters) – Reddit (RDDT.N), opens new tab shares tumbled 29% on Friday, marking their...
Oct 22 (Reuters) – IBM (IBM.N), opens new tab shares fell 6.5% in premarket trading on Thursday, as...
Oct 22 (Reuters) – Microsoft (MSFT.O), opens new tab researchers say an AI tool that diagnoses...
SAN FRANCISCO, Oct 15 (Reuters) – Amazon (AMZN.O), opens new tab unveiled two new devices on...
BANGKOK, Oct 16 (Reuters) – Finance leaders of the G7 grouping agreed to hold tabletop exercises to...
SEOUL, Oct 7 (Reuters) – AMD (AMD.O), opens new tab CEO Lisa Su said on Wednesday that the US...